PL1725232T3 - Heterocykliczne pochodne (indol-3-ilowe) jako agoniści receptora kanabinoidowego CB1 - Google Patents
Heterocykliczne pochodne (indol-3-ilowe) jako agoniści receptora kanabinoidowego CB1Info
- Publication number
- PL1725232T3 PL1725232T3 PL05716823T PL05716823T PL1725232T3 PL 1725232 T3 PL1725232 T3 PL 1725232T3 PL 05716823 T PL05716823 T PL 05716823T PL 05716823 T PL05716823 T PL 05716823T PL 1725232 T3 PL1725232 T3 PL 1725232T3
- Authority
- PL
- Poland
- Prior art keywords
- cannabinoid
- indol
- agonists
- receptor
- heterocycle derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55056304P | 2004-03-05 | 2004-03-05 | |
| EP04100902 | 2004-03-05 | ||
| EP04103901 | 2004-08-12 | ||
| EP05716823A EP1725232B1 (en) | 2004-03-05 | 2005-02-28 | (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
| PCT/EP2005/050833 WO2005089754A1 (en) | 2004-03-05 | 2005-02-28 | (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1725232T3 true PL1725232T3 (pl) | 2008-07-31 |
Family
ID=36608981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05716823T PL1725232T3 (pl) | 2004-03-05 | 2005-02-28 | Heterocykliczne pochodne (indol-3-ilowe) jako agoniści receptora kanabinoidowego CB1 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7700634B2 (pl) |
| EP (1) | EP1725232B1 (pl) |
| JP (1) | JP5011097B2 (pl) |
| AR (1) | AR048745A1 (pl) |
| AT (1) | ATE384525T1 (pl) |
| AU (1) | AU2005224041B2 (pl) |
| BR (1) | BRPI0508404A (pl) |
| CA (1) | CA2557054C (pl) |
| DE (1) | DE602005004515T2 (pl) |
| DK (1) | DK1725232T3 (pl) |
| ES (1) | ES2300995T3 (pl) |
| MY (1) | MY139070A (pl) |
| NZ (1) | NZ549386A (pl) |
| PE (1) | PE20060074A1 (pl) |
| PL (1) | PL1725232T3 (pl) |
| PT (1) | PT1725232E (pl) |
| RS (1) | RS20060502A (pl) |
| SI (1) | SI1725232T1 (pl) |
| TW (1) | TWI330635B (pl) |
| WO (1) | WO2005089754A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI330635B (en) | 2004-03-05 | 2010-09-21 | Organon Nv | (indol-3-yl)-heterocycle derivatives |
| TW200745096A (en) * | 2005-08-23 | 2007-12-16 | Organon Nv | Indole derivatives |
| US7763732B2 (en) * | 2005-08-24 | 2010-07-27 | N.V. Organon | Indole derivatives |
| GB0614062D0 (en) * | 2006-07-14 | 2006-08-23 | Glaxo Group Ltd | Compounds |
| GB0614066D0 (en) * | 2006-07-14 | 2006-08-23 | Glaxo Group Ltd | Compounds |
| TW200848417A (en) * | 2007-02-22 | 2008-12-16 | Organon Nv | Indole derivatives |
| WO2022128050A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammation and pain |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ227841A (en) * | 1988-02-12 | 1991-08-27 | Merck Sharp & Dohme | Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions |
| US4939138A (en) | 1988-12-29 | 1990-07-03 | Sterling Drug Inc. | 2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo(1,2,3-DE)-1,4-benzoxazines |
| JP2004502642A (ja) * | 2000-02-11 | 2004-01-29 | ブリストル−マイヤーズ スクイブ カンパニー | カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用 |
| AUPR118000A0 (en) * | 2000-11-02 | 2000-11-23 | Amrad Operations Pty. Limited | Therapeutic molecules and methods |
| CA2436133A1 (en) | 2001-01-29 | 2002-08-08 | University Of Connecticut | Receptor selective cannabimimetic aminoalkylindoles |
| TW200402417A (en) * | 2002-06-21 | 2004-02-16 | Akzo Nobel Nv | 1-[(Indol-3-yl)carbonyl]piperazine derivatives |
| MXPA06006928A (es) | 2003-12-17 | 2006-09-04 | Akzo Nobel Nv | Derivados de 1-[(3-indol-3-il)carbonil] piperazina ciclica como agonistas del receptor canabinoide cb1. |
| TWI330635B (en) | 2004-03-05 | 2010-09-21 | Organon Nv | (indol-3-yl)-heterocycle derivatives |
| TW200745096A (en) | 2005-08-23 | 2007-12-16 | Organon Nv | Indole derivatives |
| US7763732B2 (en) * | 2005-08-24 | 2010-07-27 | N.V. Organon | Indole derivatives |
| TW200848417A (en) | 2007-02-22 | 2008-12-16 | Organon Nv | Indole derivatives |
-
2005
- 2005-02-21 TW TW094105061A patent/TWI330635B/zh not_active IP Right Cessation
- 2005-02-28 NZ NZ549386A patent/NZ549386A/en unknown
- 2005-02-28 DE DE602005004515T patent/DE602005004515T2/de active Active
- 2005-02-28 CA CA2557054A patent/CA2557054C/en not_active Expired - Fee Related
- 2005-02-28 RS RSP-2006/0502A patent/RS20060502A/sr unknown
- 2005-02-28 BR BRPI0508404-0A patent/BRPI0508404A/pt not_active IP Right Cessation
- 2005-02-28 AU AU2005224041A patent/AU2005224041B2/en not_active Ceased
- 2005-02-28 JP JP2007501270A patent/JP5011097B2/ja not_active Expired - Fee Related
- 2005-02-28 PT PT05716823T patent/PT1725232E/pt unknown
- 2005-02-28 EP EP05716823A patent/EP1725232B1/en active Active
- 2005-02-28 PL PL05716823T patent/PL1725232T3/pl unknown
- 2005-02-28 DK DK05716823T patent/DK1725232T3/da active
- 2005-02-28 US US10/590,674 patent/US7700634B2/en not_active Expired - Fee Related
- 2005-02-28 SI SI200530186T patent/SI1725232T1/sl unknown
- 2005-02-28 WO PCT/EP2005/050833 patent/WO2005089754A1/en active IP Right Grant
- 2005-02-28 ES ES05716823T patent/ES2300995T3/es active Active
- 2005-02-28 AT AT05716823T patent/ATE384525T1/de active
- 2005-03-02 MY MYPI20050850A patent/MY139070A/en unknown
- 2005-03-04 AR ARP050100825A patent/AR048745A1/es not_active Application Discontinuation
- 2005-03-04 PE PE2005000245A patent/PE20060074A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR048745A1 (es) | 2006-05-24 |
| AU2005224041B2 (en) | 2011-03-10 |
| JP2007526281A (ja) | 2007-09-13 |
| PT1725232E (pt) | 2008-03-04 |
| JP5011097B2 (ja) | 2012-08-29 |
| US7700634B2 (en) | 2010-04-20 |
| CA2557054C (en) | 2013-02-19 |
| MY139070A (en) | 2009-08-28 |
| RS20060502A (en) | 2008-11-28 |
| BRPI0508404A (pt) | 2007-07-17 |
| TWI330635B (en) | 2010-09-21 |
| ES2300995T3 (es) | 2008-06-16 |
| AU2005224041A1 (en) | 2005-09-29 |
| EP1725232B1 (en) | 2008-01-23 |
| PE20060074A1 (es) | 2006-02-18 |
| TW200602316A (en) | 2006-01-16 |
| DE602005004515D1 (de) | 2008-03-13 |
| US20070142446A1 (en) | 2007-06-21 |
| WO2005089754A1 (en) | 2005-09-29 |
| EP1725232A1 (en) | 2006-11-29 |
| DK1725232T3 (da) | 2008-05-26 |
| DE602005004515T2 (de) | 2009-01-29 |
| CA2557054A1 (en) | 2005-09-29 |
| NZ549386A (en) | 2009-12-24 |
| SI1725232T1 (sl) | 2008-06-30 |
| ATE384525T1 (de) | 2008-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200801519B (en) | (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor | |
| HK1135966A1 (en) | Oxyindole derivatives as 5ht4 receptor agonists | |
| IL186150A0 (en) | Novel thiophene derivatives as sphingosine-1-1phosphate-1 receptor agonists | |
| IL188799A0 (en) | Substituted tetrahydro-1h-pyrido[4,3,b]indoles as serotonin receptor agonists and antagonists | |
| EP1670460A4 (en) | PYRAZOLE DERIVATIVES AS MODULATORS OF THE CANNABINOID RECEPTOR | |
| HK1140761A1 (en) | Indole derivatives as s1p1 receptor agonists | |
| EP1644335A4 (en) | TETRAHYDROQUINOLINE DERIVATIVES COMPRISING MODULATORS OF CANNABINOID RECEPTORS | |
| IL194393A0 (en) | Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands | |
| IL195071A0 (en) | Cannabinoid receptor antagonists/inverse agonists | |
| ZA200609234B (en) | Substituted azeplne derivatives as serotonin receptor modulators | |
| PT1725232E (pt) | Derivados de (indol-3-il)-heterociclo úteis como agonistas do receptor de canabinóide cb1 | |
| ZA200903075B (en) | Bridged bicyclic indazoles as cannabinoid receptor ligands | |
| IL191936A0 (en) | 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators | |
| EP2097410A4 (en) | HETEROYL-PYRAZOLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS | |
| IL194902A0 (en) | Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists | |
| IL180637A0 (en) | Tricyclic pyrazole derivatives as cannabinoid receptor modulators | |
| ZA200903829B (en) | Indole derivatives as S1P1 receptor agonists | |
| ZA200804926B (en) | 4,5-Dihydro-(1H)-Pyrazole derivatives as cannabinoid CB1 receptor modulators | |
| HK1095097A1 (en) | (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor | |
| ZA200607095B (en) | (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor | |
| IL202299A0 (en) | 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators | |
| ZA200809208B (en) | Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonists |